The story of Sildenafil offers a complicated case study for investors eyeing the pharmaceutical sector. While early sales were remarkable, present patent expiry and the arrival of generic versions have severely https://zaynabaxrs906325.like-blogs.com/40880829/sildenafil-and-the-pharmaceutical-industry-a-dangerous-stake